A study led by Csaba Kerepesi, a researcher at the Artificial Intelligence Research Laboratory of the HUN-REN Computer and Automation Research Institute, demonstrated that the occurrence of autoimmune side effects during cancer immunotherapy correlates with the tumour’s immune microenvironment, particularly the emergence of new antigens during tumour mutations, and the number of CD8+ T-cells infiltrating the tumour.